Predictions
SELLAS Life Sciences Group Inc
Start price
Target price
Perf. (%)
€2.15
15.11.22
15.11.22
-
15.11.23
15.11.23
-26.97%
24.02.23
24.02.23
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€69.50
14.11.22
14.11.22
-
14.11.23
14.11.23
239.57%
21.12.22
21.12.22
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€69.50
14.11.22
14.11.22
-
14.11.23
14.11.23
-7.91%
26.11.22
26.11.22
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€6.75
14.11.22
14.11.22
€10.00
14.11.23
14.11.23
31.66%
17.11.22
17.11.22
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€4.80
14.11.22
14.11.22
-
14.11.23
14.11.23
-13.88%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
MacroGenics Inc.
Start price
Target price
Perf. (%)
€7.15
13.11.22
13.11.22
-
13.11.23
13.11.23
-20.98%
26.11.22
26.11.22
Could be worthwhile Investment >10% per year
Jounce Therapeutics Inc
Start price
Target price
Perf. (%)
€0.96
12.11.22
12.11.22
-
12.11.23
12.11.23
-21.08%
26.11.22
26.11.22
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.12
12.11.22
12.11.22
€280.00
12.11.23
12.11.23
-87.36%
13.11.23
13.11.23
Oncopeptides AB
Start price
Target price
Perf. (%)
€1.96
12.11.22
12.11.22
€0.000
12.11.23
12.11.23
-17.89%
26.11.22
26.11.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
AstraZeneca plc
Start price
Target price
Perf. (%)
€124.30
11.11.22
11.11.22
€165.00
08.09.26
08.09.26
19.18%
13.09.24
13.09.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
Jounce Therapeutics Inc
Start price
Target price
Perf. (%)
€1.37
10.11.22
10.11.22
-
10.11.23
10.11.23
-29.49%
12.11.22
12.11.22
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€4.00
10.11.22
10.11.22
-
10.11.23
10.11.23
2.53%
26.11.22
26.11.22
Risky Investment
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€44.20
10.11.22
10.11.22
-
10.11.23
10.11.23
49.32%
02.04.23
02.04.23
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.61
09.11.22
09.11.22
-
09.11.23
09.11.23
-17.10%
26.11.22
26.11.22